HER2 expression status in diverse cancers: review of results from 37,992 patients

Overview of attention for article published in Cancer and Metastasis Reviews, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#14 of 894)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 3 news outlets
twitter: 4 X users

patent: 16 patents
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 324 Dimensions

Readers on

mendeley: 339 Mendeley

Summary News X Patents Wikipedia Dimensions citations

So far, Altmetric has seen 16 patents that reference this research output.

HER2 as a predictor of response to dual HER2 blockade in the absence of cytotoxic therapy

Grant US-11851709-B2

United States of America

End-to-end cell therapy automation

Grant US-11827902-B2

United States of America

End-to-end cell therapy automation

Grant US-11781113-B2

United States of America

Cell concentration methods and devices for use in automated bioreactors

Grant US-11773365-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 12 additional patents.